GlobeNewsWire
22 Oct 2025, 20:15 UTC · 48w ago
Verdict
Headline takes no side. We score ACRV +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 98% of ticker scores this week
Which stocks this story touches
More positive than 98% of ticker scores this week
The company announced positive preclinical data for ACR-2316 and reported confirmed partial responses during clinical dose escalation.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Market Watch
11h ago
MarketBeat
21h ago
+3.5%
Price agrees with the score
$2.06 vs $1.99 close before publication (Oct 22) · not market-adjusted
ACRV chart →
